首页 | 本学科首页   官方微博 | 高级检索  
     


Patenting humans: Clones,chimeras, and biological artifacts
Authors:William?B.?Hurlbut  author-information"  >  author-information__contact u-icon-before"  >  mailto:ethics@stanford.edu."   title="  ethics@stanford.edu."   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author
Affiliation:(1) Program in Human Biology, Stanford University, Building 80, 94305-2160 Stanford, CA, USA
Abstract:The momentum of advances in biology is evident in the history of patents on life forms. As we proceed forward with greater understanding and technological control of developmental biology there will be many new and challenging dilemmas related to patenting of human parts and partial trajectories of human development. These dilemmas are already evident in the current conflict over the moral status of the early human embryo. In this essay, recent evidence from embryological studies is considered and the unbroken continuity of organismal development initiated at fertilization is asserted as clear and reasonable grounds for moral standing. Within this frame of analysis, it is proposed that through a technique of Altered Nuclear Transfer, non-organismal entities might be created from which embryonic stem cells could be morally procured. Criteria for patenting of such non-organismal entities are considered. An earlier version of this paper was presented at an international conference, “The Ethics of Intellectual Property Rights and Patents,” held in Warsaw, Poland on 23–24 April, 2004.
Keywords:patenting humans: cloning for biomedical research  moral status of the human embryo  biological artifacts  Altered Nuclear Transfer
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号